This page shows the latest Translate Bio news and features for those working in and with pharma, biotech and healthcare.
In September the company completed its $3.2bn purchase of Translate Bio, aimed at bolstering its vaccines and mRNA capabilities, while in November it paid $1.9bn for Kadmon to strengthen
This is not the first time a major pharma company has had to refile a premerger notice; Sanofi did it when acquiring Translate Bio, and AstraZeneca refiled the notification during an
With higher R&D investment behind our pipeline assets and the two targeted bolt-on acquisitions of Translate Bio and Kadmon, we have further increased our commitment to bring innovative medicines
The data “confirms the potential” of the mRNA and lipid nanoparticle platform Sanofi acquired from Translate Bio, and also “supports Sanofi’s mRNA strategy”, said the company.
In August, Sanofi added Translate Bio’s mRNA platform to its pipeline and now it’s the turn of AstraZeneca (AZ).
Kadmon is Sanofi’s third acquisition this year. In July it acquired Translate Bio and its mRNA technology while in April it completed it acquisition of Kiadis and its immune-oncology
More from news
Approximately 4 fully matching, plus 9 partially matching documents found.
BioNTech, CureVac and Translate Bio are also working on mRNA vaccines, while Pfizer and Sanofi are involved in those programmes through partnerships with BioNTech and Translate Bio, respectively.
The second agreement, with Translate Bio, will focus on developing an mRNA vaccine for COVID-19. ... Translate has already begun to produce multiple mRNA constructs and will use its platform to discover, design and manufacture a number of coronavirus
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
US-based biotech Translate Bio has appointed Ann Barbier as its new chief medical officer. ... She said: “With near-term clinical programmes in cystic fibrosis and OTC deficiency, Translate Bio is approaching a critical and exciting time.
She joins the board of directors. Translate Bio has appointed Daniella Beckman to its board of directors and she will also serve at the US biotech as chairperson of its ... Ronald Renaud, chief executive officer, Translate Bio, said: “Daniella joins
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...